# Glenmark Pharmaceuticals Inc., USA

Canonical: https://abierto.us/vendors/glenmark-pharmaceuticals-inc-usa-pvn7ljm7ley7

- UEI: PVN7LJM7LEY7
- CAGE: 7A4E3
- Parent: Glenmark Pharmaceuticals Limited
- Location: Mahwah, NJ
- Awards in window: 2 (22 transactions), $0 obligated, February 9, 2024 to July 28, 2026

## Awarding agencies

- Department of Veterans Affairs: 2 awards, $0

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: $0

## Competition

- Full and Open Competition: 2 awards

## Largest awards

- 36E79720D0068: $0, Nac Pharmaceuticals. Cost Recovery Fee and Submission of Quarterly Sales Report Changes Effective 2/9/2024 for Aprepitant Capsules with Glenmark Pharmaceuticals, Inc., Usa. Prices Remain Unchanged.. https://www.usaspending.gov/award/CONT_IDV_36E79720D0068_3600/
- 36F79723D0012: $0, Nac Federal Supply Schedule. FSS. https://www.usaspending.gov/award/CONT_IDV_36F79723D0012_3600/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/glenmark-pharmaceuticals-inc-usa-pvn7ljm7ley7.